- All
- Featured news
- News
16Mar2023
Meet Bachem – Interview with Gilles Parmentier
We had an interview with Gilles, a seasoned Sales Manager with extensive experience in the field of ...
10Mar2023
Bachem raises CHF 108.1 million through capital increase to accelerate its growth plans
Share placement of up to 1.25 million new shares via an accelerated bookbuilding from existing autho...
09Mar2023
Bachem launches an accelerated bookbuilding for the placement of up to 1.25 million new shares to accelerate its growth plans
Share placement of up to 1.25 million new shares via an accelerated bookbuilding from existing autho...
08Mar2023
Leadership perspectives: Embracing equity on International Women’s Day
Discussion on how companies like Bachem can tap into the potential of women in "STEM" fields and car...
07Mar2023
Bachem achieves solid growth in 2022
The Bachem Group (SIX: BANB) increased sales in Swiss francs by 5.7% to CHF 531.7 million in 2022. ...
03Mar2023
Bachem signs long-term cooperation agreement for the development and supply of peptides
The order covers a committed volume at an equivalent value of over CHF 500 million for the five-year...
Careers
At Bachem, we believe that our employees make the difference. Representing our corporate culture of passion and commitment, they are the foundation of our success. We therefore strive to attract, retain, and develop highly motivated, well-qualified individuals.
View all jobs
Click here >>
Contact
We look forward to partnering with you to build up your project development plan for CMC development according to your unique needs.
No matter what stage your NCE is in – pre-IND, early or late clinical stages, or already on the market – contact us to find out what we can do for you.